Our investigation also revealed that although Bax expression is regulated positively by wild-type p53 [31], ACCA is able to induce Bax irrespective of p53 status in breast cancer cells, suggesting that alternative pathways can be involved in Bax up-regulation after treatment with ACCA. Here, TP53 is linked to breast cancer.